Mutational signatures associated with tobacco smoking in human cancer

Cited by (1,000)

Items 701–800 of 1,000

1. Pharmacological inhibition of JNK-MAPK disrupts cigarette smoke-induced RUNX2/Galectin-3 -driven EMT and cancer stemness in lung adenocarcinoma cells
   Karan Chhetri, Jiten R. Sharma, Rajesh Vasita, Rana Pratap Singh, Umesh C. S. Yadav · 2025 · Biochemical Pharmacology
2. Integrating liquid biopsy and mutational signatures to advance precision oncology
   Raquel Carrasco, Kristian Dreij · 2026 · npj Precision Oncology
3. Novel Immunohistochemical Profiling of Small-Cell Lung Cancer: Correlations Between Tumor Subtypes and Immune Microenvironment
   Alon Vigdorovits, Gheorghe‐Emilian Olteanu, Andrei Vasile Paşcalău, Radu Pîrlog, Ioana Berindan‐Neagoe, Ovidiu Laurean Pop · 2024 · Diagnostics
4. Cigarette sidestream smoke-induced cellular senescence and the protective role of histone H2AX.
   Yukako Komaki, Yuko Ibuki · 2025 · Toxicology in Vitro
5. Characterization of Mutational Signatures in Tumors from a Large Chinese Population
   Aaron A. Chevalier, Tao Guo, Natasha Q. Gurevich, Jingwen Xu, Masanao Yajima, Joshua David Campbell · 2025 · Cancer Research Communications
6. Active heavy cigarette smoking is associated with poor survival in Japanese patients with advanced renal cell carcinoma: sub-analysis of the multi-institutional national database of the Japanese Urological Association
   Tomohiko Hara, Hiroyuki Fujimoto, Tsunenori Kondo, Nobuo Shinohara, Wataru Obara, Go Kimura, Haruki Kume, Norio Nonomura, Fumiya Hongo, Takayuki Sugiyama et al. · 2017 · Japanese Journal of Clinical Oncology
7. Comparison of Clinicopathological Characteristics Between the Anterior and Posterior Type of Squamous Cell Carcinoma of the Floor of the Mouth: The Anterior Type Is a Risk Factor for Multiple Primary Cancer
   Yu Oikawa, Kae Tanaka, Toshimitsu Ohsako, Takuma Kugimoto, Takeshi Kuroshima, Hideaki Hirai, Hirofumi Tomioka, Hiroaki Shimamoto, Yasuyuki Michi, Kei Sakamoto et al. · 2021 · Frontiers in Oncology
8. Genomic and Gene Expression Studies Helped to Define the Heterogeneity of Small-Cell Lung Cancer and Other Lung Neuroendocrine Tumors and to Identify New Therapeutic Targets
   Ugo Testa, Elvira Pelosi, Germana Castelli · 2022 · Onco
9. Demystifying the black box: from ignorance to observation to mechanism in cancer research
   Peter J. Campbell · 2022 · European Journal of Epidemiology
10. A comprehensive analysis of clinical and polygenic germline influences on somatic mutational burden
    Kodi Taraszka, Stefan Groha, David King, Robert W. Tell, Kevin P. White, Elad Ziv, Noah Zaitlen, Alexander Gusev · 2024 · The American Journal of Human Genetics
11. Development and psychometric assessment of Health Action Process Approach (HAPA) in terms of smoking cessation among Chinese smokers
    Hao Tzu Lin, Haoxiang Lin, Lanchao Zhang, Chengqian Zhang, Xiaochen Yang, Wangnan Cao, Chun Ja Chang · 2024 · Scientific Reports
12. Assessing the predictive value of smoking history for immunotherapy outcomes in bladder cancer patients
    Jianqiu Kong, Yitong Zou, Hua Zhou, Yi Huang, Ying Lin, Shuogui Fang, Zhijian Chen, Junjiong Zheng, Yaqiang Huang, Zefeng Shen et al. · 2024 · Frontiers in Immunology
13. Smoking and the lung: Landmark papers (1929–2023)
    Georgi Galev, Sharada Nagoti, Irene Sansano, Susan M. Armstrong, Meredith K. Herman, Sanjay Mukhopadhyay · 2024 · Journal of diagnostic and academic pathology.
14. Tumor Mutation Signature Reveals the Risk Factors of Lung Adenocarcinoma with EGFR or KRAS Mutation
    Jialiang Wang, Chang Guo, Jiexiao Wang, Xiaopeng Zhang, Jian Qi, Xiang Huang, Zongtao Hu, Hongzhi Wang, Bo Hong · 2025 · Cancer Control
15. U2AF1 mutations rescue deleterious exon skipping induced by KRAS mutations
    David M. Walter, Katherine Cho, Smruthy Sivakumar, Daniel Denney, Iris TIENLYNN. Lee, Anders B. Dohlman, Jakob M. Heinz, Ethan Shurberg, Kevin X. Jiang, Akansha A. Gupta et al. · 2026 · Nature Genetics
16. Immunogenomic precision medicine: a personalized approach based on immunogenomic cancer evolution
    Yusaku Momoi, Shogo Kumagai, Hiroyoshi Nishikawa · 2025 · International Immunology
17. Smoking and Oral Cancer
    Brooj Abro, Shahid Pervez · 2017 · Springer eBooks
18. Somatic genome alterations in relation to age in lung adenocarcinoma
    Stefano Meucci, Ulrich Keilholz, Daniel Heim, Frederick Klauschen, Stefano Cacciatore · 2019 · International Journal of Cancer
19. Meta-analytic method reveal a significant association of theBDNF Val66Met variant with smoking persistence based on a large samples
    Hailong Zhao, Shuicai Xiong, Zhiwei Li, Xuebiao Wu, Lijuan Li · 2019 · The Pharmacogenomics Journal
20. Identification of combinations of somatic mutations that predict cancer survival and immunotherapy benefit
    Ayal B. Gussow, Eugene V. Koonin, Noam Auslander · 2021 · NAR Cancer
21. The associations of tobacco use, sexually transmitted infections, HPV vaccination, and screening with the global incidence of cervical cancer: an ecological time series modeling study
    Luyan Zheng, Yushi Lin, Jie Wu, Min Zheng · 2022 · Epidemiology and Health
22. An integrated LC-MS/MS platform for noninvasive urinary nucleus acid adductomics: A pilot study for tobacco exposure
    Xiaoqing Li, Hui Zeng, Li Zhang, Jing Zhang, Yinlong Guo, Jiapeng Leng · 2024 · Journal of Hazardous Materials
23. Association between sleep traits and risk of colorectal cancer: a bidirectional Mendelian randomization study
    Fan He, Fuyu Yang, Chenglin Tang, Defei Chen, Junjie Xiong, Yu Zou, Dongqin Zhao, Dong Peng, Kun Qian · 2024 · Journal of Gastrointestinal Oncology
24. No Impact of Smoking Status on Breast Cancer Tumor Infiltrating Lymphocytes, Response to Neoadjuvant Chemotherapy and Prognosis
    Vanille Simon, Lucie Laot, Enora Laas, Sonia Rozette, Julien Guerin, Thomas Balezeau, Marion Nicolas, Jean‐Yves Pierga, Florence Coussy, Marick E Lae et al. · 2020 · Cancers
25. Five-year Survival Rate of Bladder Cancer in Iran during 2001-2007
    Maryam Khayamzadeh, Fereshteh Aliakbari, Zahra Zolghadr, Majid Emadeddin, Mahsa Ahadi, Mohammad Esmaeil Akbari, Amir Reza Abedi, Shahrzad Nematollahi, Jalil Hosseini · 2020 · Iranian journal of pathology
26. Filling the gap between risk assessment and molecular determinants of tumor onset
    Federica Chiara, Stefano Indraccolo, Andrea Trevisan · 2020 · Carcinogenesis
27. PD-L1 as a prognostic and predictive biomarker in neuroendocrine tumors of the lung: state of the art and future perspectives
    Francesca Sanguedolce, Magda Zanelli, Stefano Ascani, Maurizio Zizzo, Simona Tortorella, Alessandra Soriano, Alfonso Fiorelli, Giorgia Cocco, Nicoletta Pia Ardò, Francesco Sollitto et al. · 2021 · Minerva Respiratory Medicine
28. Germline genomic patterns are associated with cancer risk, oncogenic pathways and clinical outcomes
    Xiaowen Feng, Xue Xu, Derek Li, Qinghua Cui, Edwin Wang · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
29. Immunotherapy as a targeted therapy in non-small cell lung cancer
    Danilo Rocco, Luigi Della Gravara, Aniello Avellino, Vincenzo Montesarchio, Ciro Battiloro · 2018 · Translational Cancer Research
30. Calculating and applying pathogen mutational spectra using MutTui
    Christopher Ruis, Gerry Q. Tonkin‐Hill, R. Andrés Floto, Julian Parkhill · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
31. Characterization of highly active mutational signatures in tumors from a large Chinese population
    Aaron A. Chevalier, Tao Guo, Natasha Q. Gurevich, Jingwen Xu, Masanao Yajima, Joshua David Campbell · 2023 · medRxiv
32. Carcinogen-induced DNA adducts amplify APOBEC mutagenesis through nucleotide excision repair
    Cameron C. Durfee, Bojana Stefanovska, Rongjie Wu, J. Caballero, Mahmoud A. Ibrahim, Michael A. Carpenter, Liping Liu, Shuvro Prokash Nandi, Prokopios P. Argyris, Luca Boscolo Bielo et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
33. Immunoprofiling bronchoalveolar lavage cells reveals multifaceted smoking-associated immune dysfunction
    Randall J. Smith, Sai Yendamuri, Yeshwanth Vedire, Spencer R. Rosario, Robert A. Zollo, Deschana Washington, Stephanie N. Sass, Nathaniel M. Ivanick, Mary E. Reid, Joseph J. Barbi · 2023 · ERJ Open Research
34. Mutational signatures in 175 Chinese gastric cancer patients
    Fatao Liu, Nan Hu, Kewei Jiang, Huaitian Liu, Mingyi Wang, Ying Hu, Tongwu Zhang, Ho‐Hsiang Wu, Howard Hua Yang, Hao Weng et al. · 2024 · BMC Cancer
35. Health implications of polycyclic aromatic hydrocarbon (PAH) exposure in humans and animals and remedial approaches
    G. S. S. Rekha, H. Hridya, Uttam Patidar, M. Sankari · 2025 · Toxicology and Environmental Health Sciences
36. A meta-analysis of experimentally validated neo-epitopes: patterns, biases, and opportunities
    Alessandro Sette, Ibel Carri, Daniel Marrama, Angela Frentzen, Jarjapu Mahita, Nina Blazeska, Randi Vita, Morten Nielsen, Yat-tsai Richie Wan, Hannah K. Carter et al. · 2025 · Cancer Immunology Immunotherapy
37. Reconstructing the lifelong history of cells and tissues via somatic mutation analysis
    Sipontina Faienza, Jean Piero Margaria, Irene Franco · 2025 · Cellular and Molecular Life Sciences
38. Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact
    Michele Carbone, Christopher Ian Amos, Richard Luther Attanoos, Mattia Boeri, Raphael Bueno, Paul A. Bunn, Lucian R. Chirieac, Benjamin Thomas Cooper, Dean Anthony Fennell, Françoise Galateau-Sallé et al. · 2026 · Journal of Thoracic Oncology
39. Subtype-specific dependencies and therapeutic opportunities in small cell lung cancer
    Amanda Luvisotto, Rima Tulaiha, Lu Wang · 2026 · Science Advances
40. Real world clinicopathologic observations of patients with metastatic solid tumors receiving immune checkpoint inhibitor therapy: Analysis from Kentucky Cancer Registry
    Aasems Jacob, Jianrong Wu, Jill Kolesar, Eric B. Durbin, Aju Mathew, Susanne M. Arnold, Aman Chauhan · 2021 · Cancer Medicine
41. Smoking Status at Time of Diagnosis Affects the Efficacy of Anti-PD-1/L1 Therapy in Patients With Advanced NSCLC
    Kyu Yean Kim, Jeong Uk Lim, HYE SEON KANG, JU SANG KIM, Sung Kyoung Kim, Seung Joon Kim, Sang Haak Lee, Chang Dong Yeo · 2023 · In Vivo
42. A Practical Site-specific Method for the Detection of Bulky DNA Damages
    Hiba Hassanain, Dana Tseitline, Tamar Hacohen, Adi Yifrach, Ayala Kirshenbaum, Bar Lavi, Avital Parnas, Sheera Adar · 2024 · Journal of Molecular Biology
43. Identifying genes associated with disease outcomes using joint sparse canonical correlation analysis—An application in renal clear cell carcinoma
    Diptavo Dutta, Ananda Sen, Jaya M. Satagopan · 2024 · Genetic Epidemiology
44. Benchmarking 13 tools for mutational signature attribution, including a new and improved algorithm
    Nanhai Jiang, Yang Wu, Steve Rozen · 2024 · Briefings in Bioinformatics
45. Sex specific familial risk in lung cancer through changing histologies in Sweden
    Kari Hemminki, Frantisek Zitricky, Kristina Sundquist, Jan Sundquist, Asta Försti, Akseli Hemminki · 2025 · International Journal of Cancer
46. Somatic genome alterations in relation to age in lung squamous cell carcinoma
    Stefano Meucci, Ulrich Keilholz, Daniel Heim, Frederick Klauschen, Stefano Cacciatore · 2018 · Oncotarget
47. Evaluation of DNA damage in tobacco associated human buccal cells using comet assay
    Shanmugam Mohanapriya, Thangadurai Maheswaran, Nalliapan Ganapathy, Thuckanaickenpalayam Ragunathan Yoithapprabhunath, Janardhanam Dineshshankar, Vadivel Ilayaraja, Rachel Sarah Vinodhini, Renuka Devi · 2021 · Medicine and Pharmacy Reports
48. BATCAVE: calling somatic mutations with a tumor- and site-specific prior
    B. Mannakee, Ryan N. Gutenkunst · 2019 · bioRxiv
49. A risk factor for newly diagnosed secondary cancer in patients with early-stage laryngeal, oropharyngeal, or hypopharyngeal cancer: sub-analysis of a prospective observation study
    Goshi Nishimura, Daisuke Sano, Yasuhiro Arai, Hideaki Takahashi, Takashi Hatano, Yosuke Kitani, Kentaro Takada, Takashi Wada, Yohei Hiiragi, Nobuhiko Oridate · 2021 · International Journal of Clinical Oncology
50. PD-L1 Expression and Intra-Tumoral CD8+ T Lymphocytes in Esophageal Carcinosarcoma
    Shusen Chen, Jiamin Zhu, Peng Wang, Dongdong Wan, Xiaojia Cui, Yunzhao Xu, Xingsong Zhang, Haibin Yin, Xudong Chen, Jing Cai et al. · 2022 · Cancer Investigation
51. DNA damage level in lymphocytes and buccal epithelial cells in Narghile smokers and non-smokers in Duhok city-KRG-Iraq
    Hishyar Najeeb, Karzan Khowaraham Karim, Galawezh Obaid Othman, Ayad Ahmad Mohammed, Ahmed Mohammed Salih, Soleen Sardar Zuhdi, Dian Jamel Salih · 2022 · Oral Oncology Reports
52. The etiology of clonal mosaicism in human aging and disease
    Sanne Massaar, Mathijs Arnoud Sanders · 2023 · Aging and Cancer
53. Clear cell renal cell carcinoma molecular variations in non‐Hispanic White and Hispanic patients
    Ken Batai, Yuliang Chen, Brenna A. Rheinheimer, Amit Arora, Ritu Pandey, Ronald L. Heimark, Erika R. Bracamonte, Nathan A. Ellis, Benjamin R. Lee · 2023 · Cancer Medicine
54. Oral squamous cell carcinoma with synchronous follicular lymphoma: A rare case report
    Nada O. Binmadi, Ghidaa Subahi, Maha Alsharif, Yara M. Daous, Basem T. Jamal, Hashim Alshinkity, Ahmed Salleh Barefah · 2024 · SAGE Open Medical Case Reports
55. Impact of LINC00312 gene polymorphism coupled with habitual risks on buccal mucosa cancer
    Hui‐Ting Hsu, Yen‐Ting Lu, Yi‐Tzu Chen, Ming‐Tai Hsing, Chun‐Wen Su, Shih‐Chi Su, Chiao‐Wen Lin, Shun‐Fa Yang · 2024 · Journal of Cancer
56. Association between smoking, smoking cessation and serum α-klotho levels among American adults: National Health and Nutrition Examination Survey
    Ting Liu, Meihua Song, Jie Li, Yumei Zhao, Weiming Zhong · 2024 · PLoS ONE
57. Topography of mutational signatures in non-small cell lung cancer: emerging concepts, clinical applications, and limitations
    Ritujith Jayakrishnan, David J. Kwiatkowski, Michal G. Rose, Amin H. Nassar · 2024 · The Oncologist
58. Not All Carcinogens Are Directly Mutagenic: A Holistic View of the Environmental Exposure–Cancer Connection
    Derick K. Okwan-Duodu, Arun R. Pandiri, David J. Adams · 2024 · Annual Review of Cancer Biology
59. Somatic mutations acquired during life: state of the art and implications for the kidney
    Jean Piero Margaria, Sipontina Faienza, Irene Franco · 2025 · Kidney International
60. Acquired SMARCA4 alterations: An uncommon contributor to cancer progression in lung adenocarcinomas
    Andréanne Gagné, Joao V. Alessi, Biagio Ricciuti, Giuseppe Lamberti, Mark Magdi Awad, Lynette Marie Sholl · 2025 · Lung Cancer
61. Genome-wide methylation profiling reveals differentially methylated genes in blood DNA of small-cell lung cancer patients
    Yanqi He, Calvin Ronchen Wei, Zhifu Sun, Julie M. Cunningham, Liang Wang, Zong Wei, Ping Yang · 2022 · Precision Clinical Medicine
62. Incidence of cancer in outpatients with chronic obstructive pulmonary disease
    Juan Marco Figueira Gonçálves, Rafael Dorta Sánchez, L.I. Pérez Méndez, Lorenzo Manuel Pérez Negrín, Ignacio García‐Talavera, Alicia Pérez Rodríguez, David Díaz-Pérez, Pedro Viña Manrique, Cristina Guzmán Saenz · 2017 · Revista Clínica Española (English Edition)
63. The first complete Zoroastrian-Parsi mitochondrial reference genome and genetic signatures of an endogamous non-smoking population
    Villoo Morawala Patell, Naseer Pasha, Kashyap Krishnasamy, Bharti Mittal, Chellappa Gopalakrishnan, Raja Mugasimangalam, Naveen Sharma, Arati-Khanna Gupta, Perviz Bhote-Patell, Sudha Rao et al. · 2021 · Meta Gene
64. Clinical features and prognosis of duplex primary malignant neoplasms involving chronic myeloid leukemia
    Chunshui Liu, Cong Wang, Zhonghua Du, Hongwei Xue, Zhihe Liu · 2020 · Medicine
65. Einfluss des Rauchens auf den Gastrointestinaltrakt
    Sabine Popp, Thomas G. Mang, Martina Scharitzer · 2022 · Die Radiologie
66. Mutational analysis on gastric, duodenal, bone, and mediastinal lymph node metastases and blood from a case of primary lung adenocarcinoma
    Xin Yang, Rui Chen, Chen Wu, Weiqing Zhao, Mei Ji · 2018 · OncoTargets and Therapy
67. Simultaneous renal clear cell carcinoma and primary clear cell carcinoma of the liver
    Hua Jiang, Shan‐Chao Zhao, Ganhong Li · 2020 · Medicine
68. Large scale analysis of smoking-induced changes in the tumor immune microenvironment
    Arghavan Alisoltani, Xinru Qiu, Lukasz Jaroszewski, Mayya Sedova, Zhanwen Li, Adam Godzik · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
69. Genome-scale multi-organ analysis of mutagenic effects of ethanol and acetaldehyde in Sprague Dawley rats
    Bérénice Chavanel, Eva Tibaldi, François Virard, Christine Carreira, Sergey Senkin, Behnoush Abedi‐Ardekani, Vincent Cahais, Michael Korenjak, Zdenko Herceg, Silvia Balbo et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
70. Cerebral Cortical Vasodilation via Nicotinic Receptors by Heated Tobacco Product Aerosol Extract in Rats
    Sae Uchida, Jura Moriya, Daichi Morihara, Mayura Shimura, Fusako Kagitani · 2024 · Journal of Vascular Research
71. Comparative effects of combustible cigarette versus electronic cigarette exposures on KRAS mutant lung cancer promotion
    Walter V. Velasco, Maria T. Grimaldo, Nastaran Karimi, Michael J. Clowers, Avantika Krishna, Ranran Wu, Rahmah Ejaz, Bo Yuan, Segundo W Del Aguila, Iman Bouchelkia et al. · 2025 · Neoplasia
72. Optimizing Tobacco-Free Workplace Programs: Applying Rapid Qualitative Analysis to Adapt Interventions for Texas Healthcare Centers Serving Rural and Medically Underserved Patients
    Hannah Wani, Maggie Britton, Tzuan A. Chen, Ammar D. Siddiqi, Asfand B. Moosa, Teresa Williams, Kathleen B. Casey, Lorraine R. Reitzel, Isabel Martinez Leal · 2025 · Cancers
73. COVID-19 and Lung Cancer Interactions: A Literature Review
    Szabolcs-Attila László, Edith Simona Ianoși, Anca-Meda Văsieșiu, Mioara Szathmáry, Maria Beatrice Ianoși, Delia-Liana Rachiș, Gabriel Nistor, Gabriela Jimborean · 2025 · Medical Sciences
74. Application and mechanistic research of novel therapeutic strategies in cisplatin-resistant small cell lung cancer
    Zhe Chen, Min Qiang, Junxue Dong, Kejian Gong, Xinjun Zhang, Peng Huo, Jingjun Zhu, Yifeng Shao, Jianzun Ma, Bowei Zhang et al. · 2026 · Annals of Medicine
75. Target-induced polymerase inhibition and self-catalytic DNAzyme/CHA cascaded amplifications for highly sensitive fluorescent detection of BPDE-DNA adduct
    Yating Xiang, Huaifeng Yan, Daxiu Li, Bingying Jiang, Yun Xiang, Ruo Yuan · 2026 · Sensors and Actuators B Chemical
76. Mutational signature-based classification uncovers emerging oral cancer subtypes with distinct molecular patterns
    Sophie Deneuve, Béatrice Fervers, Júlia S. Bruno, Emma Bach, Sergey Senkin, Gabrielle Goldman‐Lévy, Christine Carreira, Israa A. Laklouk, Rong Hu, Liacine Bouaoun et al. · 2026 · International Journal of Oral Science
77. Cracking the enigma of mitochondrial-DNA variants and cancer
    Wei Wei, Patrick Francis Chinnery · 2020 · Nature Metabolism
78. The most frequent Polish ATM mutations are not susceptibility factors for tobacco-related cancers
    Marta Podralska, Agnieszka Dzikiewicz‐Krawczyk, Maria Mosor, Magdalena Żurawek, Katarzyna Iżykowska, Ryszard Słomski, Małgorzata Rydzanicz, Piotr Gabryel, Wojciech Dyszkiewicz, Iwona Ziółkowska‐Suchanek · 2020 · Archives of Medical Science
79. L’instabilité génomique, paramètre limitant l’efficacité des thérapies ciblées en oncologie
    Amandine Billaud, Louise-Marie Chevalier, Mario Campone, Alain Morel, Frédéric Bigot · 2020 · Bulletin du Cancer
80. Elevated APOBEC mutational signatures implicate chronic injury in etiology of an aggressive head-and-neck squamous cell carcinoma: a case report
    Jena Patel, Nicoline Y. den Breems, Madalina Tuluc, Jennifer Maria Johnson, Joseph Curry, Andrew P. South, Raymond Jaihyun Cho · 2021 · Journal of Medical Case Reports
81. Nature of spontaneously arising single base substitutions in normal cells
    Shunichi Takeda, Yang Luan · 2021 · Genome Instability & Disease
82. Excerno: Using Mutational Signatures in Sequencing Data to Filter False Variants Caused by Clinical Archival
    Audrey Mitchell, Marco Ruiz, Soua Yang, Chen Wang, Jaime I Davila · 2022 · Journal of Computational Biology
83. Tobacco smoking associates with NF1 mutations exacerbating survival outcomes in gliomas
    Xi Li, Han Yan, Jun Wu, Longbo Zhang · 2022 · Biomarker Research
84. Identification of multiplicatively acting modulatory mutational signatures in cancer
    Dovydas Kičiatovas, Qingli Guo, Miika Kailas, Henri Pesonen, Jukka Corander, Samuel Kaski A, Esa Pitkänen, Ville Mustonen · 2022 · BMC Bioinformatics
85. Mutagenesis induced by protonation of single-stranded DNA is linked to glycolytic sugar metabolism
    Suzana P. Gelova, Kin Chan · 2023 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
86. The Effect of Sexual Myths on Quality of Sexual Life, Marital Satisfaction and Self-Esteem in Married Women with Physically Disabled
    Türkan Akyol Güner · 2023 · Özgür Yayınları eBooks
87. Synchronous multiple primary neoplasms of the esophagus, rectosigmoid and central nervous system
    Suvendu Sekhar Jena, Samiran Nundy · 2024 · International Journal of Surgery Case Reports
88. XPC Protects against Carcinogen-Induced Histologic Progression to Lung Squamous Cell Carcinoma by Reduced Basal Epithelial Cell Proliferation
    Catherine R. Sears, Huaxin Zhou, Emily L. Hulsey, Bea Aidoo, George Earl Sandusky, Nawar Al Nasrallah · 2024 · Cancers
89. Molecular Compositions, Mutagenicity, and Mutation Spectra of Atmospheric Oxidation Products of Alkenes and Dienes Initiated by NOx + UV or Ozone: A Structure–Activity Analysis
    Michael Lewandowski, Theran P. Riedel, Jonathan D. Krug, Tadeusz E. Kleindienst, Matthew J. Meier, Alexandra S. Long, Sarah H. Warren, David M. DeMarini · 2024 · Environmental Science & Technology
90. Discovery of Novel RASGRF2 Fusions as a Therapeutic Target in Lung Adenocarcinoma of Never or Light Smokers
    Yuki Terashima, Soohwan Park, Hiroshi Ikeuchi, Takuo Hayashi, Shinya Kojima, Toshihide Ueno, Masachika Ikegami, Rina Kitada, Yoshiyuki Suehara, Shinya Tanaka et al. · 2025 · Cancer Science
91. Habitual napping and cancer incidence: a prospective study from the UK Biobank with metabolomic mediation analysis
    Juan He, Xinyi Wu, Wenjun Ye, Feng Li, Yi Feng, Xiangyuan Zheng, Yuling Wu, Jingjia Cai, Yihai Wei, Jingwen Diao et al. · 2025 · SLEEP
92. Mortalidad por cáncer asociado al consumo de cigarrillo en el Caribe colombiano, 2009-2013
    Kyara Herrera Pamplona, Zuleima Cogollo-Milanés, Luis Alvis Estrada · 2019 · Revista Facultad Nacional de Salud Pública
93. Perfil de tabagismo e frequência de micronúcleos em indivíduos de um município do Sul de Minas Gerais
    Vanessa Pereira dos Santos, Natan Barbosa Nogueira, José Dias da Silva Neto, Rodrigo Machado Pereira · 2021 · Revista Eletrônica Acervo Saúde
94. Mutational pattern of PIK3CA exon 20 in circulating DNA in breast cancer
    Iman Hassan Ibrahim, Heba Gamal Abd El-Aziz, Noha N. Amer, hesham abd al-samee · 2022 · Saudi Journal of Biological Sciences
95. Immuntherapie von Tumorerkrankungen mit Checkpoint-Inhibitoren
    Andreas Neubauer · 2017 · Der Internist
96. Genomics in Primary and Secondary Prevention of Pancreatic Cancer
    Núria Malats, Esther Molina‐Montes, Carlo La Vecchia · 2017 · Public Health Genomics
97. Incidencia de cáncer en pacientes ambulatorios con enfermedad pulmonar obstructiva crónica
    Juan Marco Figueira Gonçálves, Rafael Dorta Sánchez, Lina Pérez‐Méndez, Lorenzo Manuel Pérez Negrín, Ignacio García‐Talavera, Alicia Pérez Rodríguez, David Díaz-Pérez, Pedro Viña Manrique, Cristina Guzmán Saenz · 2017 · Revista Clínica Española
98. Smoking Behavior and Cessation (Nicotine Addiction): Are Genetic Factors Involved in Smoking Behavior?
    Tetsuya Kubota, Akihito Yokoyama · 2018 · Respiratory disease series
99. Lung Cancer Prevention
    Eva M. Szabo · 2019 · Springer eBooks
100. Cell plasticity and genomic instability in cancer evolution
     Yan Kang Xu, Hui Li, Fan Yang, Dingpeng Yang, Bin‐Bing S. Zhou · 2020 · Genome Instability & Disease